Limits of 18F-Fluorodeoxyglucose positron emission tomography in recurrence diagnosis of borderline ovarian tumor

Margherita Giorgini; Claudia Marchetti; Violante Di Donato; Jacopo Tesei; Natalina Manci; Pierluigi Benedetti Panici

doi:10.1111/IGC.0b013e3181da2912

Limits of 18F-Fluorodeoxyglucose positron emission tomography in recurrence diagnosis of borderline ovarian tumor

Margherita Giorgini, Claudia Marchetti, Violante Di Donato, Jacopo Tesei, Natalina Manci, Pierluigi Benedetti Panici

University of Rome La Sapienza

Research output: Contribution to journal › Article

Abstract

Most borderline ovarian tumors (BOT) occur in young women and exhibit a low malignant behavior. Nevertheless, an accurate long-term follow-up is required because, frequently, recurrence arises after many years from primary treatment, especially in patients affected by BOTwith invasive peritoneal implants, which have aworse prognosis.We report the case of a pelvic recurrence of serous BOT firstly suspected by physical examination but misdiagnosed by 18F-fluorodeoxyglucose positron emission tomography and computed tomography and identified only by magnetic resonance imaging, 7 years after primary treatment. We also reviewed the literature concerning the role of 18F-fluorodeoxyglucose positron emission tomography in the management and follow-up of BOT. Copyright © 2010 by IGCS and ESGO.

Original language	English
Pages (from-to)	694-697
Number of pages	4
Journal	International Journal of Gynecological Cancer
Volume	20
DOIs	https://doi.org/10.1111/IGC.0b013e3181da2912
Publication status	Published - 2010

Keywords

Borderline ovarian tumors
Recurrence
Total-body FDG-PET/CT

Access to Document

10.1111/IGC.0b013e3181da2912

Cite this

@article{9db0c35b3099465e9ae0fb26c5e2cd90,

title = "Limits of 18F-Fluorodeoxyglucose positron emission tomography in recurrence diagnosis of borderline ovarian tumor",

abstract = "Most borderline ovarian tumors (BOT) occur in young women and exhibit a low malignant behavior. Nevertheless, an accurate long-term follow-up is required because, frequently, recurrence arises after many years from primary treatment, especially in patients affected by BOTwith invasive peritoneal implants, which have aworse prognosis.We report the case of a pelvic recurrence of serous BOT firstly suspected by physical examination but misdiagnosed by 18F-fluorodeoxyglucose positron emission tomography and computed tomography and identified only by magnetic resonance imaging, 7 years after primary treatment. We also reviewed the literature concerning the role of 18F-fluorodeoxyglucose positron emission tomography in the management and follow-up of BOT. Copyright {\textcopyright} 2010 by IGCS and ESGO.",

keywords = "Borderline ovarian tumors, Recurrence, Total-body FDG-PET/CT, Borderline ovarian tumors, Recurrence, Total-body FDG-PET/CT",

author = "Margherita Giorgini and Claudia Marchetti and {Di Donato}, Violante and Jacopo Tesei and Natalina Manci and Panici, {Pierluigi Benedetti}",

year = "2010",

doi = "10.1111/IGC.0b013e3181da2912",

language = "English",

volume = "20",

pages = "694--697",

journal = "International Journal of Gynecological Cancer",

issn = "1048-891X",

publisher = "Blackwell Science Incorporated:350 Main Street, Sixth Floor:Malden, MA 02148:(888)661-5800, (781)388-8250, EMAIL: csjournals@blacksci.com, INTERNET: http://www.blackwell-science.com, Fax: (781)388-8232",

}

TY - JOUR

T1 - Limits of 18F-Fluorodeoxyglucose positron emission tomography in recurrence diagnosis of borderline ovarian tumor

AU - Giorgini, Margherita

AU - Marchetti, Claudia

AU - Di Donato, Violante

AU - Tesei, Jacopo

AU - Manci, Natalina

AU - Panici, Pierluigi Benedetti

PY - 2010

Y1 - 2010

N2 - Most borderline ovarian tumors (BOT) occur in young women and exhibit a low malignant behavior. Nevertheless, an accurate long-term follow-up is required because, frequently, recurrence arises after many years from primary treatment, especially in patients affected by BOTwith invasive peritoneal implants, which have aworse prognosis.We report the case of a pelvic recurrence of serous BOT firstly suspected by physical examination but misdiagnosed by 18F-fluorodeoxyglucose positron emission tomography and computed tomography and identified only by magnetic resonance imaging, 7 years after primary treatment. We also reviewed the literature concerning the role of 18F-fluorodeoxyglucose positron emission tomography in the management and follow-up of BOT. Copyright © 2010 by IGCS and ESGO.

AB - Most borderline ovarian tumors (BOT) occur in young women and exhibit a low malignant behavior. Nevertheless, an accurate long-term follow-up is required because, frequently, recurrence arises after many years from primary treatment, especially in patients affected by BOTwith invasive peritoneal implants, which have aworse prognosis.We report the case of a pelvic recurrence of serous BOT firstly suspected by physical examination but misdiagnosed by 18F-fluorodeoxyglucose positron emission tomography and computed tomography and identified only by magnetic resonance imaging, 7 years after primary treatment. We also reviewed the literature concerning the role of 18F-fluorodeoxyglucose positron emission tomography in the management and follow-up of BOT. Copyright © 2010 by IGCS and ESGO.

KW - Borderline ovarian tumors

KW - Recurrence

KW - Total-body FDG-PET/CT

KW - Borderline ovarian tumors

KW - Recurrence

KW - Total-body FDG-PET/CT

UR - http://hdl.handle.net/10807/205144

U2 - 10.1111/IGC.0b013e3181da2912

DO - 10.1111/IGC.0b013e3181da2912

M3 - Article

SN - 1048-891X

VL - 20

SP - 694

EP - 697

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

ER -

Limits of 18F-Fluorodeoxyglucose positron emission tomography in recurrence diagnosis of borderline ovarian tumor

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this